DTCT EU 24 Roundtable 10:45 1 Seminars

10:45AM - 11:45AM

Roundtable Discussion: Leveraging Disruptive Technology Whilst Setting Up Clinical Trials: Challenges and Opportunities

Speaker

  • Dr Fabian Kreimendahl Medical Evidence Biostatistics Manager - The Janssen Pharmaceutical Companies of Johnson & Johnson
10:45AM - 11:45AM

Roundtable Discussion: Leveraging Disruptive Technology Whilst Setting Up Clinical Trials: Challenges and Opportunities

Speaker

  • Dr Fabian Kreimendahl Medical Evidence Biostatistics Manager - The Janssen Pharmaceutical Companies of Johnson & Johnson